An independent organization that acts collaboratively across the pediatric community to accelerate pediatric drug development, all to achieve better health for children around the world: I-ACT for Children.
Your Pediatric Research Powerhouse
By creating connections between pediatric research and drug development stakeholders, the Institute for Advanced Clinical Trials for Children (I-ACT for Children) increases efficiencies and inspires innovation from protocol to clinical trials to labeling.
Our powerhouse pediatric site network, experienced resources and clinical expertise uniquely suit I-ACT for Children to deliver outcomes that close the pediatric development gap. All these capabilities support our sole focus: provide the best treatments to children, faster.
The I-ACT for Children Mission
To serve the pediatric community as an independent and connected organization to accelerate the clinical development of innovative therapeutic solutions to improve health outcomes in children.
The Latest From I-ACT for Children
Rapid COVID-19 Advisory Board Assembly
Inclusion of Adolescents in Adult Clinical Trials
I-ACT Chief Medical Officer Gary Noel, M.D., was the lead author on a report from the I-ACT for Children Pediatric Research Innovation Forum. The paper, which was published in the…
Innovative Therapies for Children With IBD
Inflammatory bowel disease (IBD) is no longer rare in children, but addressing their needs during IBD therapy development remains challenging. This webinar series explores solutions to advance regulatory approval pathways,…
Thank You to Our Sustaining Members
